LEAH Labs is building a discovery engine for cell therapy development using virus-free gene editing technology, with dogs and cancer as a beachhead market.
Dogs and humans get the same types of diseases, especially cancers, and are great models for one another. Our company is the first to bring CAR-T cell therapy to pets as both an unmet need for companion animal medicine, but also as a platform to discover and de-risk potential human assets. We operate under USDA jurisdiction, a regulatory environment prime for innovation that is orders of magnitude more cost effective to iterate within than FDA.